发明名称
摘要 <p>Compounds of general formula I: wherein: R1 and R2 are, independently of each other, selected from hydrogen, optionally substituted C1-10alkyl, optionally substituted -CO-(C1-10alkyl), optionally substituted C3-10cycloalkyl, optionally substituted -CO-(C3-10cycloalkyl), optionally substituted C2-10alkenyl, optionally substituted -CO-(C2-10alkenyl), optionally substituted aryl, and optionally substituted -CO-aryl, or R1 and R2 together represent an optionally substituted saturated or unsaturated C1-10alkylidene group, or an optionally substituted saturated or unsaturated C3-10cycloalkylidene group, or R1 and R2 together with the carbon atom to which they are attached represent an optionally substituted saturated or unsaturated organic ring containing 3, 4, 5, 6, 7 or 8 ring carbon atoms and optionally 1, 2 or 3 ring heteroatoms selected from O, N and S; R3, which may be the same as, or different from, either of R1 and R2, is selected from optionally substituted C1-10alkyl, optionally substituted C3-10cycloalkyl, optionally substituted C2-10alkenyl, and optionally substituted aryl; R4, R5 and R6 are, independently of each other, selected from hydrogen, optionally substituted C1-10alkyl, OH, optionally substituted C1-10 alkoxy, halo, optionally substituted aryloxy, optionally substituted (C1-10alkyl)-S(O)n- where n=0, 1 or 2, optionally substituted aryl-S(O)n- where n=0, 1 or 2, or R4 is hydrogen and R5 and R6 together represent an optionally substituted saturated or unsaturated organic chain containing 1, 2, 3, 4, 5, 6 or 7 chain carbon atoms and optionally 1, 2 or 3 chain heteroatoms selected from O, N and S, provided that the chain is at least 3 atoms long; with the proviso that, when R1-R2=hydrogen, then any optionally substituted C1-10alkyl or optionally substituted C2-10alkenyl for R3 must have a branch point at one or more of the alpha and beta positions counted from the carbonyl group (or tautomeric form thereof) to which R3 is attached; or a physiologically acceptable salt, complex or prodrug thereof; are disclosed per se and for use in the treatment or prophylaxis of hypersensitivity, smooth muscle disorders, spasmodic conditions, allergic conditions, inflammatory conditions and/or pain.</p>
申请公布号 JP5397903(B2) 申请公布日期 2014.01.22
申请号 JP20090517431 申请日期 2007.07.05
申请人 发明人
分类号 C07C49/255;A23L1/30;A23L2/52;A61K31/121;A61K31/138;A61K31/235;A61K31/275;A61K31/695;A61P1/00;A61P1/02;A61P1/04;A61P1/06;A61P1/10;A61P1/12;A61P1/14;A61P1/16;A61P1/18;A61P3/04;A61P9/00;A61P9/10;A61P9/12;A61P11/02;A61P11/04;A61P11/06;A61P11/14;A61P13/10;A61P15/00;A61P15/06;A61P17/04;A61P17/06;A61P19/02;A61P21/00;A61P25/08;A61P25/14;A61P27/16;A61P29/00;A61P37/00;A61P37/08;A61P43/00;C07B61/00;C07C45/73;C07C45/74;C07C49/577;C07C49/84;C07C67/343;C07C213/08 主分类号 C07C49/255
代理机构 代理人
主权项
地址